Social Values and Health Priority Setting Sarah Clark and Albert Weale University College London NICE International Health Priority Setting Conference.

Slides:



Advertisements
Similar presentations
National Treatment Agency September 2009 Needs Assessment and the balanced treatment system 25 October 2010 London.
Advertisements

Implementing NICE guidance
Interpreting Social Values in Health Sarah Clark University College London Presentation to UCL Conference: ‘How Can We Set Priorities in Health Fairly?’
Evidence-Based Decision Making: The Contribution of Systematic Reviews in Synthesizing Evidence.
Introduction to the User’s Guide for Developing a Protocol for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research.
How do we achieve cost effective cancer treatments in the UK? Professor Peter Littlejohns Department of Public Health and Primary Care.
1 Requiring Immunizations for Health Care Workers: Fair and Just? Lisa M Lee, PhD, MS 2014 HEAL Conference April 11, 2014.
Barbara M. Altman Emmanuelle Cambois Jean-Marie Robine Extended Questions Sets: Purpose, Characteristics and Topic Areas Fifth Washington group meeting.
CEET Conference 2011 Funding VET for Social Inclusion Competitive tendering and contestable funding in VET: approaches to supporting access and equity.
Institute of Health Policy and Management Taking the Right to Health Care Seriously Martin Buijsen Health Care Rationing Conference Rotterdam, 9 December.
Making Decisions in Health Care: Cost-effectiveness and the Value of Evidence Karl Claxton Centre for Health Economics, Department of Economics and Related.
Health Technology Assessment and evidence-informed decision making
BALANCING EFFICIENCY AND EQUITY A NEW INTERNATIONAL RESEARCH PROGRAMME ADDRESSING THE ROLE OF VALUES IN HEALTH CARE Department of Primary Care and Public.
International Seminar on Drug Advertising Canadian Experience Brazilian Health Surveillance Agency and Pan American Health Organization Brasilia, Brazil.
Subject Selection and Recruitment David Wendler Department of Clinical Bioethics NIH, USA.
Use of Children as Research Subjects What information should be provided for an FP7 ethical review?
A METHODOLOGY FOR MEASURING THE COST- UTILITY OF EARLY CHILDHOOD DEVELOPMENTAL INTERVENTIONS Quality of improved life opportunities (QILO)
Risk Management and Strategy Prioritisation Intelligence Step 8 - Risk Management and Strategy Prioritisaiton Considering the risks associated with action.
A tisket, a tasket, is MNCH in your benefits basket? March 2, 2015.
Promoting Excellence in Family Medicine Enabling Patients to Access Electronic Health Records Guidance for Health Professionals.
Health Systems and the Cycle of Health System Reform
Guidelines for the reporting of evidence identification in decision models: observations and suggested way forward Louise Longworth National Institute.
Health Care guaranteed – The Right to Health in Germany Which Lessons could be learned about or from Germany? Remarks by Franz Knieps, Managing Partner.
Designing Influential Evaluations Session 2 Topics & Timing Uganda Evaluation Week - Pre-Conference Workshop 19 th and 20 th May 2014.
Care Options for NHS Continuing Health Care (CHC) Wirral PCT Board – 12 February 2008 Tina Long - Director of Strategic Partnerships Sheila Hillhouse -
Human Rights and Patient Care Anahit Harutyunyan Armenia.
Copyright 2011 Right Care The Accountable Integrated Care System Sept 2011 Commissioning for Value.
Impact Evaluation of Health Insurance for Children: Evidence from Vietnam Proposal Presentation PEP-AusAid Policy Impact Evaluation Research Initiative.
TRANSFORMATION IN HEALTH CARE: ARE WE THERE YET? Thulani Matsebula.
Lukas Steinmann Mexico 10. June 2008 To your health: diagnosing the state of healthcare and the global private medical insurance industry.
Health promotion and its national context
EVIDENCE BASED MEDICINE Health economics Ross Lawrenson.
AIDS IN ASIA – PRIORITIZING AND SUSTAINING THE RESPONSE IN THE ECONOMIC CRISIS Hanoi September 2009 ADB Consultant Ross McLeod.
Considering the Costs of MUS Interventions. Direct Costs v. Opportunity Costs Direct Costs Expenditures and investments to achieve a particular outcome.
Health Economics Unit Definition of Economics  Demand − relationship between quantities and prices that addresses how much bought at each price.
Introduction to MAST Kristian Kidholm Odense University Hospital, Denmark.
Workshop The science and methodologies behind HTA, diversity and commonality across the EU Achieving more patient centred HTA in different countries.
Title: Patient Centred Care for Vulnerable Older People in the Community Nurse Consultants Meeting July 07 Presenter: Clare Abley, Nurse Consultant Vulnerable.
© Nuffield Trust 27 February 2012 A survey of GPs in England on the rationing of health care Survey results.
Themes Emerging from Country and Related Presentations Notes from session 1545 – 1730 Thursday 17 February 2011 Albert Weale.
By Julius T. Tweve THE ROLE OF PUBLIC LIBRARIES IN NATIONAL DEVELOPMENT IN TANZANIA: INFORMATION INCLUSION AND EXCLUSION.
Tuberculosis and the Ethics of Shared Responsibility Ross E.G. Upshur, BA(HONS), MA, MD, MSc, CCFP, FRCPC Canada Research Chair in Primary Care Research.
Improving Total System Performance & Public-private Partnership Dr. FUNG Hong Hospital Authority May 2001.
DIFFICULT DECISIONS IN HEALTH CARE Presentation to OJHOSC Dr Ljuba Stirzaker Oxfordshire Primary Care Trust 13 March 2008 ITEM JHO8(a) JHO3.MAR1308R03.ppt.
Consent & Vulnerable Adults Aim: To provide an opportunity for Primary Care Staff to explore issues related to consent & vulnerable adults.
Nottingham Trent University Alternative Futures Conference 2014 The OECD concept of the ‘Strategic State’ and its application to 3 inter-related areas.
NIHR Themed Call Prevention and treatment of obesity Writing a good application and the role of the RDS 19 th January 2016.
HPTN Ethics Guidance for Research: Community Obligations Africa Regional Working Group Meeting, May 19-23, 2003 Lusaka, Zambia.
Who is involved in making NICE guidance recommendations and what evidence do they look at? Jane Cowl, Senior Public Involvement Adviser Tommy Wilkinson,
NURSING’S HEATH POLICY AGENDA ANA (2008) credit to Patrick Robinson, PhD, RN, ACRN Executive Assistant Dean University of Illinois at Chicago College of.
© University of South Wales Royal College of Speech and Language Therapists Outcomes Conference and Hub Launch Belfast, May 1, 2014 Running a tight ship:
An Imperfect Model for Democratic Decision Making Gemma Stacey, Philip Houghton & James Shutt Representing Critical Values Based Practice Network
Our application to become an NHS Foundation Trust.
Priority Setting in healthcare in Chile: considerations of Social Value Judgements Marianela Castillo-Riquelme Newton-Picarte Project London, 30 of March.
R ESEARCH PLANNING. Research planning is a process through which we transform our ideas into a well-planned, ethical and realistic research project.
Learning from patients’ experience Angela Coulter Picker Institute Europe Angela Coulter Picker Institute Europe
The NHS Constitution and patient rights and responsibilities Jessica Britton Associate Director of Quality and Assurance.
Uterovaginal Prolapse
Ethical Issues in Health
Uterovaginal Prolapse
Adherence to Evidence Based Medicine Programme Evidence Summary Pack (Version 2) Hernia Local commissioners working with local people for a healthier.
Human Rights and Patient Care
DETERMINING FUTILE TREATMENTS
Lisbon Conference ‘Health care rationing in Europe’, 26 October 2018
Chapter 4 © Routledge/Taylor & Francis 2014
Adherence to Evidence Based Medicine Programme Evidence Summary Pack (Version 2) Correction of Ptosis Local commissioners working with local people for.
Arthritis and Musculoskeletal Alliance
What are the benefits of Primary Care Networks for patients?
How can we make healthcare purchasing in Kenya more strategic?
Presentation transcript:

Social Values and Health Priority Setting Sarah Clark and Albert Weale University College London NICE International Health Priority Setting Conference London, February 2011

Aims  Not a literature review!  To provoke further thought on values outlined in background paper  To explore the range of interpretations of the values

Process values: Transparency How might we define transparency?  Everyone knows who makes decisions  Everyone knows who makes decisions and by what processes  Everyone knows who makes decisions, by what processes and for what reasons Basic transparency of institutional arrangements Transparency of institutional decision making processes Full transparency of institution, processes and criteria

Process Values: Accountability To whom is accountability owed?..... And accountability for what? Priority Setters Clinical effectiveness Value judgements Patients Clinical effectiveness Value judgements Health professionals Financial Expenditure Cost effectiveness TaxpayersInsurance payers Meeting basic entitlements The Courts

Process Values: Participation Who might participate? Patients, health professionals, experts, taxpayers, insurance payers, citizens…. Why value participation?  If people have their say, then they can’t complain at the result  Decisions are more legitimate if different interests can contribute  It improves the quality of decisions  Those whose money is being spent should have a say in what it’s used for The more of these reasons apply, the more we move from consultation to control.

Content Values: Clinical Effectiveness How to define clinical effectiveness?  Any intervention showing some evidence of benefit  Only interventions that definitely provide benefits  Only interventions that definitely provide benefit to patients, and are better than available alternatives Uncertain, lack of evidence, but available – solidarity? Certainty, good evidence but patients may wait Patients take a risk – autonomy? Minimal risk to patients – paternalist?

Content Values: Cost-Effectiveness How important is cost- effectiveness, relative to other values?  It’s just one factor amongst many and should not have privileged status  It’s one of the most important factors but not always decisive – however it might be unusual for other values to over-rule it  It’s of primary and decisive importance Strong focus on individual- related values, eg. dignity Less focus on individual-related values, more on collective ones, eg. opportunity costs Who benefits can be important Doesn’t matter who benefits – QALY is a QALY is a QALY

Content Values: Justice/Equity What might justice/equity require in priority setting?  All patients with the same condition should be treated the same  Some patients should be ‘positively’ prioritised because of their status – eg. vulnerable populations, the young, the poor, people with dependents  Some patients should be ‘negatively’ prioritised because they are responsible for their condition Health is the only relevant factor Factors other than health should be taken into consideration Treats all individual patients the same; expresses health solidarity; May consider people other than patient; may express socio- economic solidarity; Focus on individual; autonomy important; may factor in capacity to benefit.

Content Values: Solidarity What might solidarity require?  All have access to ‘comprehensive care’, however defined  All have access to a ‘basic package’, however defined  Entirely private arrangements Full social solidarity Partial solidarity Weak solidarity

Content Values: Autonomy How important is autonomy? Autonomy as personal preference and personal responsibility  We should give low priority to individual preferences, and individual responsibility should not condition access to treatment.  People should be able to exercise some preferences over some care  People are responsible for spending their own money and for their own lifestyle choices Individualistic focus for priorities Priorities set collectively

Some questions…..  What other values? Eg. dignity, compassion …??  How do process and content values relate to one another?  What might lead some countries to prioritize some values over others?